A5036154207- Diabetes Management and Education
- Chronic Disease Management Strategies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pharmaceutical Practices and Patient Outcomes
- Biomedical Ethics and Regulation
- Health Systems, Economic Evaluations, Quality of Life
- Primary Care and Health Outcomes
- Nursing Diagnosis and Documentation
- Pharmaceutical Economics and Policy
- Mental Health and Patient Involvement
- Health and Wellbeing Research
- Biomedical and Engineering Education
- Computational Drug Discovery Methods
- Health, psychology, and well-being
- Healthcare Systems and Technology
- Academic Publishing and Open Access
- Biosimilars and Bioanalytical Methods
- Biotechnology and Related Fields
- CAR-T cell therapy research
Newcastle University
2017-2024
University of Manchester
2015-2017
Self-management is recognised as an essential criteria for the provision of high quality care chronic obstructive pulmonary disease (COPD). The management COPD usually delivered by a wide range healthcare practitioners. This study aimed to understand factors affecting self-management from perspectives different multidisciplinary teams involved in care. Semi-structured interviews were conducted with participants primary care, specialist respiratory and rehabilitation (PR) teams. Purposive...
Advanced therapy medicinal products (ATMPs) are innovative biological categorised as either gene, somatic cell, tissue-engineered or combined therapies. As of March 2022, 12 ATMPs marketed in the EU and UK. We identified 482 unique within 616 technology records from National Institute for Health Care Research Innovation Observatory database, 4 which currently marketed. These were 583 clinical trials. Of records, 57.1% gene therapies 1.6% Records covered various indications, including 130...
Background Self-care support is an 'inseparable' component of quality healthcare for long-term conditions (LTCs). Evidence how patients view and use community pharmacy (CP) to engage in self-care LTCs limited. Objective To explore patients' perspectives engaging CP support. Setting England Scotland. Method Qualitative design employing semi-structured interviews. were recruited via general practitioners (GPs) CPs. Interviews conducted between May 2013 June 2014; they audio-recorded,...
To explore community pharmacists' contributions to self-care support of long-term conditions by; investigating their conceptual understanding principles; identifying activities they considered important and engagement in them; examining barriers enablers.A questionnaire was developed using existing literature qualitative interviews, piloted distributed online a random sample 10 000 pharmacists England between August November 2014. The contained sections addressing the above objectives. Data...
Abstract Objectives It is vital that horizon scanning organizations can capture and disseminate intelligence on new repurposed medicines in clinical development. To our knowledge, there are no standardized classification systems to this intelligence. This study aims create a novel system allow be disseminated healthcare organizations. Methods A multidisciplinary working group undertook literature searching an iterative, three-stage piloting process build consensus system. Supplementary data...
Introduction The COVID-19 pandemic led to a significant surge in clinical research activities the search for effective and safe treatments. Attempting disseminate early findings from trials bid accelerate patient access promising treatments, rise use of preprint repositories was observed. In UK, NIHR Innovation Observatory (NIHRIO) provided primary horizon-scanning intelligence on global multi-agency initiative therapeutics. This included signals preliminary results support selection,...
Introduction Early identification of innovative medicines is crucial for timely health technology assessment (HTA) and efficient patient access. The National Institute Health Research Innovation Observatory (NIHRIO) identifies, monitors notifies key HTA stakeholders in England ‘technologies’ (innovative medicines) within three to five years regulatory approval. Increasing numbers significant uncertainties clinical pathways are major challenges the monitoring notification process. An active...
Introduction While horizon-scanning systems aim to identify innovative and potentially disruptive health technologies in development, a key challenge is variation information collation tracking of the pace change prior regulatory approval. An active efficient monitoring process crucial for timely notification technology assessment (HTA) stakeholders enhance faster market patient access. The National Institute Health Research Innovation Observatory (NIHRIO) identifies notifies its HTA England...